Surgery最新文献

筛选
英文 中文
Prospects of probiotic Escherichia coli Nissle 1917 in the treatment of septic shock. 益生菌大肠杆菌鼻喷剂1917在感染性休克治疗中的应用前景。
IF 3.2 2区 医学
Surgery Pub Date : 2025-05-01 Epub Date: 2024-12-28 DOI: 10.1016/j.surg.2024.109031
Ya-Jie Wang, Yi-Sheng Pan
{"title":"Prospects of probiotic Escherichia coli Nissle 1917 in the treatment of septic shock.","authors":"Ya-Jie Wang, Yi-Sheng Pan","doi":"10.1016/j.surg.2024.109031","DOIUrl":"10.1016/j.surg.2024.109031","url":null,"abstract":"","PeriodicalId":22152,"journal":{"name":"Surgery","volume":" ","pages":"109031"},"PeriodicalIF":3.2,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142898268","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment on "Effect of systemic FOLFOXIRI plus bevacizumab treatment of colorectal peritoneal metastasis on local and systemic immune cells". 评论“全身性FOLFOXIRI联合贝伐单抗治疗结直肠腹膜转移对局部和全身免疫细胞的影响”。
IF 3.2 2区 医学
Surgery Pub Date : 2025-05-01 Epub Date: 2024-12-30 DOI: 10.1016/j.surg.2024.109012
Xiaoxia Liu, Chong-Jie Zhang
{"title":"Comment on \"Effect of systemic FOLFOXIRI plus bevacizumab treatment of colorectal peritoneal metastasis on local and systemic immune cells\".","authors":"Xiaoxia Liu, Chong-Jie Zhang","doi":"10.1016/j.surg.2024.109012","DOIUrl":"10.1016/j.surg.2024.109012","url":null,"abstract":"","PeriodicalId":22152,"journal":{"name":"Surgery","volume":" ","pages":"109012"},"PeriodicalIF":3.2,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142910777","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advancing the understanding of conversional and revisional metabolic bariatric surgery outcomes on obstructive sleep apnea. 促进对阻塞性睡眠呼吸暂停的转换和修正代谢减肥手术结果的理解。
IF 3.2 2区 医学
Surgery Pub Date : 2025-05-01 Epub Date: 2024-12-30 DOI: 10.1016/j.surg.2024.109013
Chen Zhou, Chenglong Liang
{"title":"Advancing the understanding of conversional and revisional metabolic bariatric surgery outcomes on obstructive sleep apnea.","authors":"Chen Zhou, Chenglong Liang","doi":"10.1016/j.surg.2024.109013","DOIUrl":"10.1016/j.surg.2024.109013","url":null,"abstract":"","PeriodicalId":22152,"journal":{"name":"Surgery","volume":" ","pages":"109013"},"PeriodicalIF":3.2,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142910825","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter to the editor: "The impact of frailty on long-term functional outcomes in severely injured geriatric patients". 致编辑的信:“虚弱对严重受伤的老年患者的长期功能结果的影响”。
IF 3.2 2区 医学
Surgery Pub Date : 2025-05-01 Epub Date: 2024-12-06 DOI: 10.1016/j.surg.2024.108957
Xianwen Shi, Lingjia Xu
{"title":"Letter to the editor: \"The impact of frailty on long-term functional outcomes in severely injured geriatric patients\".","authors":"Xianwen Shi, Lingjia Xu","doi":"10.1016/j.surg.2024.108957","DOIUrl":"10.1016/j.surg.2024.108957","url":null,"abstract":"","PeriodicalId":22152,"journal":{"name":"Surgery","volume":" ","pages":"108957"},"PeriodicalIF":3.2,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142792326","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Model of End-Stage Liver Disease–alpha-fetoprotein–tumor burden (MELD-AFP-TBS) score to stratify prognosis after liver resection for hepatocellular carcinoma 终末期肝病-甲胎蛋白-肿瘤负荷模型(MELD-AFP-TBS)评分对肝癌肝切除术后预后进行分层
IF 3.2 2区 医学
Surgery Pub Date : 2025-04-30 DOI: 10.1016/j.surg.2025.109388
Jun Kawashima MD , Miho Akabane MD , Mujtaba Khalil MD , Selamawit Woldesenbet MD , Yutaka Endo MD , Kota Sahara MD , Andrea Ruzzenente MD , Francesca Ratti MD , Hugo P. Marques MD , Sara Oliveira MD , Jorge Balaia MD , François Cauchy MD , Vincent Lam MD , George A. Poultsides MD , Minoru Kitago MD , Irinel Popescu MD , Guillaume Martel MD , Ana Gleisner MD , Tom Hugh MD , Matthew Weiss MD , Timothy M. Pawlik MD, PhD, MPH, MTS, MBA, FACS, FSSO, FRACS (Hon.)
{"title":"Model of End-Stage Liver Disease–alpha-fetoprotein–tumor burden (MELD-AFP-TBS) score to stratify prognosis after liver resection for hepatocellular carcinoma","authors":"Jun Kawashima MD ,&nbsp;Miho Akabane MD ,&nbsp;Mujtaba Khalil MD ,&nbsp;Selamawit Woldesenbet MD ,&nbsp;Yutaka Endo MD ,&nbsp;Kota Sahara MD ,&nbsp;Andrea Ruzzenente MD ,&nbsp;Francesca Ratti MD ,&nbsp;Hugo P. Marques MD ,&nbsp;Sara Oliveira MD ,&nbsp;Jorge Balaia MD ,&nbsp;François Cauchy MD ,&nbsp;Vincent Lam MD ,&nbsp;George A. Poultsides MD ,&nbsp;Minoru Kitago MD ,&nbsp;Irinel Popescu MD ,&nbsp;Guillaume Martel MD ,&nbsp;Ana Gleisner MD ,&nbsp;Tom Hugh MD ,&nbsp;Matthew Weiss MD ,&nbsp;Timothy M. Pawlik MD, PhD, MPH, MTS, MBA, FACS, FSSO, FRACS (Hon.)","doi":"10.1016/j.surg.2025.109388","DOIUrl":"10.1016/j.surg.2025.109388","url":null,"abstract":"<div><h3>Introduction</h3><div>Morphologic criteria, such as the Barcelona Clinic Liver Cancer staging system often fail to accurately predict long-term survival among patients undergoing liver resection for hepatocellular carcinoma. We sought to develop a continuous risk score that incorporates established markers of tumor biology and liver function to improve the prediction of overall survival.</div></div><div><h3>Methods</h3><div>Data from a multi-institutional database were used to identify patients who underwent curative-intent hepatectomy for hepatocellular carcinoma. A predictive score for overall survival was developed using weighted beta-coefficients from a multivariable Cox regression model.</div></div><div><h3>Results</h3><div>Among 850 patients, 595 (70.0%) were assigned to the training cohort, and 255 (30.0%) to the test cohort. In the training cohort, multivariable analysis identified the Model of End-Stage Liver Disease (hazard ratio, 1.04; 95% confidence interval, 1.01–1.07), log-transformed alpha-fetoprotein (hazard ratio, 1.07; 95% confidence interval, 1.02–1.13), and tumor burden score (hazard ratio, 1.07; 95% confidence interval, 1.03–1.11) as independent predictors of worse overall survival. The Model of End-Stage Liver Disease–alpha-fetoprotein–tumor burden score, based on the Cox model, stratified patients into low-risk (<em>n</em> = 466, 78.3%) with a 5-year OS of 70.5% and high-risk (<em>n</em> = 129, 21.7%) with a 5-year OS of 47.0% (<em>P</em> &lt; .001). In the test cohort, the Model of End-Stage Liver Disease–alpha-fetoprotein–tumor burden score demonstrated superior discriminative accuracy (C-index: 0.72, time-dependent area under the curve 1-year: 0.80, 3-year 0.76, 5-year 0.70) compared with the Barcelona Clinic Liver Cancer staging system (C-index: 0.53, time-dependent area under the curve 1-year: 0.61, 3-year 0.55, 5-year 0.56). An online tool was made accessible at <span><span>https://jk-osu.shinyapps.io/MELD_AFP_TBS/</span><svg><path></path></svg></span>.</div></div><div><h3>Conclusion</h3><div>The Model of End-Stage Liver Disease–alpha-fetoprotein–tumor burden score provides a novel, accurate tool for prognostic stratification of patients with hepatocellular carcinoma, identifying high-risk patients who may benefit from alternative treatments to improve outcomes.</div></div>","PeriodicalId":22152,"journal":{"name":"Surgery","volume":"183 ","pages":"Article 109388"},"PeriodicalIF":3.2,"publicationDate":"2025-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143891840","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is preoperative smoking status a predictor of postoperative outcomes after esophagectomy for squamous cell carcinoma in a high-volume centre? 在一个大容量中心,术前吸烟状况是食管切除术后鳞状细胞癌预后的预测因子吗?
IF 3.2 2区 医学
Surgery Pub Date : 2025-04-29 DOI: 10.1016/j.surg.2025.109379
Alexandre Lintis MD , Thibault Voron MD, PhD , Guillaume Passot MD, PhD , Sebastien Degisors MD , Marguerite Messier MD , Clarisse Eveno MD, PhD , Guillaume Piessen MD, PhD , Julie Veziant MD, PhD
{"title":"Is preoperative smoking status a predictor of postoperative outcomes after esophagectomy for squamous cell carcinoma in a high-volume centre?","authors":"Alexandre Lintis MD ,&nbsp;Thibault Voron MD, PhD ,&nbsp;Guillaume Passot MD, PhD ,&nbsp;Sebastien Degisors MD ,&nbsp;Marguerite Messier MD ,&nbsp;Clarisse Eveno MD, PhD ,&nbsp;Guillaume Piessen MD, PhD ,&nbsp;Julie Veziant MD, PhD","doi":"10.1016/j.surg.2025.109379","DOIUrl":"10.1016/j.surg.2025.109379","url":null,"abstract":"<div><h3>Background</h3><div>Smoking is a major risk factor for esophageal squamous cell carcinoma (ESCC) and is linked to increased postoperative morbidity. However, its impact on long-term survival remains unclear. This study evaluated the influence of preoperative smoking status on postoperative complications and survival following esophagectomy for ESCC in a high-volume center.</div></div><div><h3>Methods</h3><div>Patients who underwent surgery for ESCC between 1996 and 2019 were retrospectively categorized as smokers (S-group) or non-smokers (NS-group). A subgroup analysis was performed to compare active and former smokers. Primary outcomes included major postoperative complications (Clavien-Dindo ≥ III), pulmonary complications, and postoperative mortality at 30 and 90 days. Long-term outcomes included overall survival (OS) and recurrence-free survival (RFS).</div></div><div><h3>Results</h3><div>Among 694 patients, 97 (14%) were in the NS-group and 597 (86%) in the S-group. Smokers had significantly higher major morbidity rates (37% vs 23%, <em>P</em> = .002), including major pulmonary complications (29% vs 21%, <em>P</em> = .03). Active smoking was associated with increased 30-day mortality (<em>P</em> = .006) and higher rates of acute respiratory distress syndrome (<em>P</em> = .012) compared to former smokers. OS and RFS did not differ significantly between groups. The absence of post-operative smoking data limits long-term outcome interpretation.</div></div><div><h3>Conclusion</h3><div>Smoking was associated with increased perioperative morbidity, particularly pulmonary complications, but its effect on long-term survival remains uncertain. Structured smoking cessation programs should be integrated into perioperative care. Future studies should incorporate postoperative smoking status to better assess its impact on survival.</div></div>","PeriodicalId":22152,"journal":{"name":"Surgery","volume":"183 ","pages":"Article 109379"},"PeriodicalIF":3.2,"publicationDate":"2025-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143881397","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patterns of care and surgical outcomes for early-stage rectal cancer in the United States 美国早期直肠癌的护理模式和手术结果
IF 3.2 2区 医学
Surgery Pub Date : 2025-04-29 DOI: 10.1016/j.surg.2025.109374
Julia Kohn MD , Anthony I. Squillaro MD , Alexander Troester MD , Sarah L. Mott MS , Melanie Quick BS , Lindsay Welton MD , Christine Jensen MD , Imran Hassan MD , Paolo Goffredo MD
{"title":"Patterns of care and surgical outcomes for early-stage rectal cancer in the United States","authors":"Julia Kohn MD ,&nbsp;Anthony I. Squillaro MD ,&nbsp;Alexander Troester MD ,&nbsp;Sarah L. Mott MS ,&nbsp;Melanie Quick BS ,&nbsp;Lindsay Welton MD ,&nbsp;Christine Jensen MD ,&nbsp;Imran Hassan MD ,&nbsp;Paolo Goffredo MD","doi":"10.1016/j.surg.2025.109374","DOIUrl":"10.1016/j.surg.2025.109374","url":null,"abstract":"<div><h3>Background</h3><div>Although limited trials have demonstrated the feasibility of rectal-preserving approaches in clinical T1-3N0 adenocarcinoma, local excision after neoadjuvant therapy has been associated with high rates of morbidity. We hypothesized that this strategy would be comparable to the standard, total mesorectal excision. The aim of this study was to describe trends of early-stage rectal cancer management.</div></div><div><h3>Methods</h3><div>cT1-3N0 rectal cancers in the National Cancer Database (2006–2018) were grouped into 5 treatments: total mesorectal excision, total neoadjuvant therapy + local excision, neoadjuvant chemoradiotherapy + local excision, total neoadjuvant therapy + total mesorectal excision, and neoadjuvant chemoradiotherapy + total mesorectal excision. Morbidity was defined as a combination of readmissions and 30- and 90-day mortality.</div></div><div><h3>Results</h3><div>We identified 22,793 patients. Neoadjuvant chemoradiotherapy + local excision had the highest proportion of patients ≥70 years (41%) and those with comorbidities (Charlson-Deyo score ≥2, 9%). Median stay was 1 day for local excision and 5 days for total mesorectal excision. Overall composite morbidity was 9%, which, after adjustment, was not statistically different between local excision and total mesorectal excision (odds ratio = 0.45, 95% confidence interval: 0.17–1.19). Among local excision patients, 56% had pathologic complete response, 33% were pStage I, and 12% pStage II-III. In multivariable analysis, all strategies had similar overall survival compared with total mesorectal excision, except for neoadjuvant chemoradiotherapy + local excision, which was associated with worse prognosis (hazard ratio = 1.57, 95% confidence interval: 1.21–2.03).</div></div><div><h3>Conclusion</h3><div>Although infrequent, neoadjuvant chemoradiotherapy/total neoadjuvant therapy + local excision were associated with high rates of tumor downstaging, suggesting that rectal-preserving strategies are feasible. However, 1 in 8 patients had more advanced disease, which may have compromised future total mesorectal excision planes. Together with the similar morbidity and relatively worse prognosis of neoadjuvant chemoradiotherapy + local excision, these observations should prompt careful patient selection for this approach, while cautioning against its widespread use.</div></div>","PeriodicalId":22152,"journal":{"name":"Surgery","volume":"183 ","pages":"Article 109374"},"PeriodicalIF":3.2,"publicationDate":"2025-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143881402","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter to the editor on "Impact of biliary drainage method before pancreaticoduodenectomy on short- and long-term outcomes in patients with periampullary carcinoma and obstructive jaundice: A multicenter retrospective analysis". 致编辑的信“胰十二指肠切除术前胆道引流方法对壶腹周围癌合并梗阻性黄疸患者短期和长期预后的影响:一项多中心回顾性分析”。
IF 3.2 2区 医学
Surgery Pub Date : 2025-04-29 DOI: 10.1016/j.surg.2025.109380
Jiawei Zhang, Xiangbo Chen
{"title":"Letter to the editor on \"Impact of biliary drainage method before pancreaticoduodenectomy on short- and long-term outcomes in patients with periampullary carcinoma and obstructive jaundice: A multicenter retrospective analysis\".","authors":"Jiawei Zhang, Xiangbo Chen","doi":"10.1016/j.surg.2025.109380","DOIUrl":"https://doi.org/10.1016/j.surg.2025.109380","url":null,"abstract":"","PeriodicalId":22152,"journal":{"name":"Surgery","volume":" ","pages":"109380"},"PeriodicalIF":3.2,"publicationDate":"2025-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144054732","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter to the editor: Methodologic and statistical considerations for comparative studies on radical antegrade modular pancreatosplenectomy. 致编辑的信:根治性顺行模块化胰脾切除术比较研究的方法学和统计学考虑。
IF 3.2 2区 医学
Surgery Pub Date : 2025-04-28 DOI: 10.1016/j.surg.2025.109371
Xiang Zhou, Shunqi Xie
{"title":"Letter to the editor: Methodologic and statistical considerations for comparative studies on radical antegrade modular pancreatosplenectomy.","authors":"Xiang Zhou, Shunqi Xie","doi":"10.1016/j.surg.2025.109371","DOIUrl":"https://doi.org/10.1016/j.surg.2025.109371","url":null,"abstract":"","PeriodicalId":22152,"journal":{"name":"Surgery","volume":" ","pages":"109371"},"PeriodicalIF":3.2,"publicationDate":"2025-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143982946","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter to the editor regarding: "The impact of complication-sensitive risk models on hospital benchmarking for failure to rescue". 致编辑的信:“并发症敏感风险模型对医院抢救失败基准的影响”。
IF 3.2 2区 医学
Surgery Pub Date : 2025-04-28 DOI: 10.1016/j.surg.2025.109382
Venkata Dileep Kumar Veldi, Rachana Mehta, Ranjana Sah
{"title":"Letter to the editor regarding: \"The impact of complication-sensitive risk models on hospital benchmarking for failure to rescue\".","authors":"Venkata Dileep Kumar Veldi, Rachana Mehta, Ranjana Sah","doi":"10.1016/j.surg.2025.109382","DOIUrl":"https://doi.org/10.1016/j.surg.2025.109382","url":null,"abstract":"","PeriodicalId":22152,"journal":{"name":"Surgery","volume":" ","pages":"109382"},"PeriodicalIF":3.2,"publicationDate":"2025-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144044641","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信